Pyronaridine clinical trials
Counted the way a researcher would: Pyronaridine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses pyronaridine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the pyronaridine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2022 (2); 2 more planned to start later
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 4
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2) · Medicines for Malaria Venture (2) · London School of Hygiene and Tropical Medicine (1) · Merck Sharp & Dohme LLC (1) · Armaceutica, Inc. (1) · Armed Forces Research Institute of Medical Sciences, Thailand (1)
Often tested with
Tested in the same studies.
Cabamiquine (2) · Atovaquone, proguanil drug combination (2) · Artesunate (2) · Piperaquine (1) · Primaquine (1) · MK-7602 (1) · Pyronaridine tetraphosphate, artesunate drug combination (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test pyronaridine.
- Apr 2027A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)Phase 1 · Merck Sharp & Dohme LLC
Studies
Open first, then newest update. How each study uses pyronaridine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT07919028Written as Pyronaridine
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedPhase 2Armaceutica, Inc.NCT05291390Written as Pyronaridine Tetraphosphate
- Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05974267Written as Pyronaridine
- Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05689047Written as Pyronaridine 360 mg
- Pyronaridine in Healthy Adult Participants Infected With Blood Stage MalariaCompletedPhase 1Medicines for Malaria VentureNCT05287893Written as Pyronaridine
- A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine TetraphosphateCompletedPhase 1Medicines for Malaria VentureNCT05160363Written as Pyronaridine Tetraphosphate
- Drug Combinations of Atovaquone-Proguanil (AP) With ACTStatus unknownPhase 4Armed Forces Research Institute of Medical Sciences, ThailandNCT03726593Written as Artesunate and Pyronaridine
- Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT04049916Written as Pyronaridine Tetraphosphate/Artesunate
What changed recently
From the registry's own updates since Oct 17, 2026.
Stopped1
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedOct 19, 2026NCT05291390
Newly registered1
- A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)Nov 5, 2026NCT07919028
Codes
What other systems call pyronaridine · ClinicalTrials.gg INT002864
- MeSH (NLM) C027871pyronaridineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) TD3P7Q3SG6PYRONARIDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q7263674pyronaridineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90737PyronaridineOne source FDA
- DrugBank DB12975One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C027871 | pyronaridine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | TD3P7Q3SG6 | PYRONARIDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7263674 | pyronaridine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90737 | Pyronaridine | One source FDA |
| DrugBank | DB12975 | — | One source Wikidata |
Also registered as pyronaridine tetraphosphate (UNII 2T289F9ACO).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.